Answers are grounded in this paper and cite their sources.
Neuroblastoma (NBL) is one of the most common solid tumors and around 15% of cancer mortality in children. Amplification of the N-Myc proto-oncogene is strongly correlated with advanced disease and poor clinical outcome in NBL. Recent studies described that ubiquitin-specific protease 7 (USP7; also known as HAUSP) interacts with N-Myc, induces deubiquitination and subsequent stabilization of N-Myc that in-turn potentiates N-Myc function, and treatment with the HAUSP inhibitor (P22077) blocked such effects.
No takes yet. Share an insight, caveat, or question.
Md Kamrul Hasan (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: